-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Amneal Pharmaceuticals, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from 2017 to 2024.
- Amneal Pharmaceuticals, Inc. Amortization of Intangible Assets for the quarter ending March 31, 2024 was $39.9 M, a 2.92% decline year-over-year.
- Amneal Pharmaceuticals, Inc. Amortization of Intangible Assets for the twelve months ending March 31, 2024 was $162 M, a 5.98% decline year-over-year.
- Amneal Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2023 was $163 M, a 5.17% decline from 2022.
- Amneal Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2022 was $172 M, a 0.35% decline from 2021.
- Amneal Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2021 was $173 M, a 1.3% decline from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)